Sanofi unveils name for new API company

Jan. 14, 2021

Last February, Sanofi announced plans to spin off an API company that would become the biggest pharma ingredients provider in Europe. Now the company has a name.

Dubbed EUROAPI, the company is aiming for $1.2 billion in sales by 2022. Sanofi also projects that the company, which will be headquartered in France, “will rank number 1 in small molecules API, and number 2 on the global API market. 

EUROAPI was launched to help secure Europe’s supply of critical pharma ingredients. Sanofi plans to own a 30 percent stake in the company and be one of its customers. Sanofi says that the company will also use “state-of-the-art industrial capabilities and technologies.”

Read the press release.